Fillipos Koinis

Characterization of DLL3-positive circulating tumor cells (CTCs) in patients with small cell lung cancer (SCLC) and evaluation of their clinical relevance during front-line treatment

Ippokratis Messaritakis, Fillipos Koinis, Eleni Politaki et al. · Lung Cancer · 2019 · 35 citations

Medicine, Cell Biology, Oncology +15

TTF-1- and/or CD56-positive Circulating Tumor Cells in patients with small cell lung cancer (SCLC)

Ippokratis Messaritakis, Dimitris Stoltidis, Αthanasios Kotsakis et al. · Scientific Reports · 2017 · 33 citations · Full text

Medicine, Oncology, Pathology +16

Bcl-2 expression in circulating tumor cells (CTCs) of patients with small cell lung cancer (SCLC) receiving front-line treatment

Ippokratis Messaritakis, Michail Nikolaou, Eleni Politaki et al. · Lung Cancer · 2018 · 31 citations

Medicine, Cancer Biology, Oncology +14

Predictive value of ATP7b, BRCA1, BRCA2, PARP1, UIMC1 (RAP80), HOXA9, DAXX, TXN (TRX1), THBS1 (TSP1) and PRR13 (TXR1) genes in patients with epithelial ovarian cancer who received platinum-taxane first-line therapy

Spyros Pontikakis, Chara Papadaki, Maria Tzardi et al. · The Pharmacogenomics Journal · 2016 · 18 citations

Medicine, Molecular Genetics, Oncology +16

Dynamic changes of phenotypically different circulating tumor cells sub-populations in patients with recurrent/refractory small cell lung cancer treated with pazopanib

Ippokratis Messaritakis, Eleni Politaki, Fillipos Koinis et al. · Scientific Reports · 2018 · 16 citations · Full text

Medicine, Oncology, Pharmacology +15